openPR Logo
Press release

Subcutaneous Immunoglobulin (SCIg) Market: Technologies, Markets and Players

04-12-2017 07:34 PM CET | Health & Medicine

Press release from: Transparency Market Research – Pharmaceutical

Subcutaneous Immunoglobulin (SCIg) Market: Technologies,

Immunoglobulin, commonly known as an antibody, is a Y-shaped protein manufactured primarily by plasma cells. Immunoglobulin is utilized by the immune system to counterbalance pathogens. Subcutaneous injections are administered as vaccines and medications including insulin and immunoglobulin. The process of administering immunoglobulin is known as immunoglobulin therapy. When immunoglobulin therapy is applied below the dermis and epidermis, or cutis, it is known as subcutaneous immunoglobulin. Subcutaneous therapy is useful as it offers a sustained rate of absorption.

Download The Full Brouchre of Report http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20594

Immunoglobulin replacement therapy (IRT) is the systematic care for patients with antibody deficit. Immunoglobulin replacement therapy can be of two types: subcutaneous immunoglobulin (SCIg) and intravenous immunoglobulin (IVIg). The choice of treatment depends upon numerous factors such as clinical symptoms, patient physiognomies, intravenous access, and possible side effects. However, subcutaneous immunoglobulin infusions for immunoglobulin replacement therapy (IRT) are more efficient, and these have a satisfactory safety profile along with good tolerance level. Advantages of the subcutaneous route include reduced adverse effects, partial deviation in peak and trough immunoglobulin (Ig) levels, decreased need for vascular access and improved patient autonomy. Subcutaneous immunoglobulin can be administered to most patients where clinically appropriate, and with pertinent learning and follow up care. These factors are likely to fuel the growth of the global subcutaneous immunoglobulin market.

Government regulations such as approvals from the Food and Drug Administration is an essential factor likely to shape the global subcutaneous immunoglobulin market. Subcutaneous immunoglobulin requires frequent administration and some patients might need battery driven pumps for taking subcutaneous immunoglobulin. This is likely to hamper the growth of the market. However, subcutaneous immunoglobulin can be administered at home without IV (intravenous) access, thereby making it a cheap alternative as compared to intravenous immunoglobulin. Moreover, ease of use and high movability of subcutaneous immunoglobulin makes them a preferred choice for immune deficient patient. According to a report by the National Center for Biotechnology Information, globally, over 6 million people suffer from primary immune deficiency alone. Therefore, the subcutaneous immunoglobulin market is likely to witness strong growth in the next few years.

The global resonators market can be segmented based on condition, end-user, and region. In terms of condition, the market can be segmented into primary immune deficiency and secondary immune deficiency. Primary immune deficiency accounted for the largest share of the global subcutaneous immunoglobulin market and is likely to dominate the market during the forecast period. Based on end-user, the market can be segmented into hospitals, private medical clinics, residential use, and others. Hospitals held the major share of the global market. However, the residential segment is projected to expand at a high growth rate during the forecast period driven by increasing adoption of subcutaneous immunoglobulin.

Browse Global Strategic Business Report: http://www.transparencymarketresearch.com/subcutaneous-immunoglobulin-market.html

Geographically, the global subcutaneous immunoglobulin market can be segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America held the dominant share of the global market. Presence of key players and availability of subcutaneous immunoglobulin as well as rising adoption of advanced medical services has resulted in the dominance of this region. However, Asia Pacific is likely to grow at a substantial rate due to rise in primary immune deficiency in the region.

The global subcutaneous immunoglobulin market is characterized by the existence of a number of players. With all dealers competing to gain significant market shares, the market is very competitive in nature. Companies are competing on the basis of price and early approvals from the regulatory authorities such as the FDA.

Key players in the market include CSL Behring AG, Shire plc, Baxter International AG, Biotest AG, CUVITRU Baxalta US, Inc., Baxter Healthcare Corporation, Vivaglobin CSL, Hizentra CSL Behring AG, HYQVIA, and Behring GmbH.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Subcutaneous Immunoglobulin (SCIg) Market: Technologies, Markets and Players here

News-ID: 500710 • Views: 442

More Releases from Transparency Market Research – Pharmaceutical

Plasma Protease C1-inhibitor Treatment Market Estimated to Flourish by 2025
A fresh market intelligence study by Transparency Market Research (TMR) states that the business landscape of the global plasma protease c1-inhibitor treatment market is consolidated with intense competitive rivalry among leading players. TMR detects Shire plc led the global plasma protease C1-inhibitor treatment market in 2016. Key factors that account for its dominance are expanded product portfolio, acquisitions, and widespread market presence. Pharming Group N.V., CSL Limited, and Sanquin are
Narcolepsy Market - Global Industry Trends and Forecast - 2019
Narcolepsy is a chronic neurological disorder, which is characterized by brain’s inability to control the sleep-wake cycle of an individual. This disorder is not caused due to any mental illness, but is mainly caused due to genetic abnormalities occurring from environmental factors or biologic factors. Narcoleptic individuals exhibita typical characteristic symptom, i.e. excessive daytime sleepiness (EDS), where individuals experience disturbed night sleep and abnormal daytime sleep pattern. Narcolepsy disorder is
Diabetic Macular Edema Market - Key Growth Factors and Forecast 2019
Macular edema is the condition when the fluid and proteins start collecting on or under the macula of the eye thereby resulting in swelling. Due to such swelling, a person’s central eye vision gets distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME). Obtain Report Details @ http://www.transparencymarketresearch.com/diabetic-macular-edema-market.html Diabetic macular edema is the major reason for loss of vision in patients
Primary Systemic Amyloidosis Market- Get Facts About Business Strategies and Fin …
Amyloids are the substance made up of abnormally formed protein in the bone marrow that gets saturated in different tissues or organs of the body. The condition is termed as amyloidosis. There are various types of amyloidosis out of which primary systemic amyloidosis are most common, these are associated with plasma cell dyscrasia and has no historical evidence of disease. Kidney, intestines, liver, heart and nerves are the common organs

All 5 Releases


More Releases for Immunoglobulin

Immunoglobulin Market Opportunity Analysis, 2018-2026
Immunoglobulins are critical part of the immune response, which specifically recognize and bind to particular antigens such as bacteria or viruses aiding in their inhibition. Immunoglobulins also called as antibodies are the glycoprotein molecules produced by plasma cells i.e. white blood cells. The antibody immune response is highly complex and very specific. The various immunoglobulin classes and subclasses (isotypes) differ in their biological features, structure, target specificity and distribution. Hence,
Intravenous Immunoglobulin (IVIg) Market Professional Survey Report
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from
Immunoglobulin Market Projected To Reach $13,619 Million By 2023
Immunoglobulins (IGs) are glycoproteins produced in the blood plasma in response to the antigens, which are foreign to the host system. They are highly complex entities and specific in their action. They are obtained from blood by fractionation process and purified for therapeutic and non-therapeutic applications. In therapeutics, they are administered intravenously in the treatment of various deficiencies. The global immunoglobulin was valued at $8,374 million in 2016, and is
Intravenous Immunoglobulin Market Analysis & Trends 2024
Transparency Market Research estimates that the global intravenous immunoglobulin (IVIG) market, which was valued at US$7.23 bn in 2015, is projected to expand at a CAGR of 8.5% from 2016 to 2024 and reach US$14.92 bn in 2024. In terms of end users, the hospitals segment is presently leading, accounting for a more than 62% of the overall market in 2015. The segment is, however, expected to lose prominence to
Global Subcutaneous Immunoglobulin Market | MarketResearchReports.biz
Latest industry research report on: Global Subcutaneous Immunoglobulin Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Global Subcutaneous Immunoglobulin Market: Overview Primary humoral immunodeficiency or primary immune deficiency diseases (PIDD) is a group of disorders in which the immune system of an individual does not function properly. In PIDD patients, the number of antibodies produced in the body is not sufficient, or the ones produced are
Global Immunoglobulin Market Research Report 2017
Report Hive Market Research Released a New Research Report of 163 pages on Title " Global Immunoglobulin Market Research Report 2017 "with detailed Analysis, Forecast and Strategies. Immunoglobulin Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united